|
Volumn 90, Issue 6, 2004, Pages 617-
|
Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant α-galactosidase A
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA GALACTOSIDASE;
RECOMBINANT ALPHA GALACTOSIDASE A;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CASE REPORT;
CLINICAL FEATURE;
DIASTOLE;
ECHOCARDIOGRAPHY;
ENZYME ACTIVITY;
FABRY DISEASE;
FLOW RATE;
GENE MUTATION;
HEART DISEASE;
HEART EJECTION FRACTION;
HEART FUNCTION;
HEART LEFT VENTRICLE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART VENTRICLE FUNCTION;
HEART VENTRICLE HYPERTROPHY;
HUMAN;
IMAGE ANALYSIS;
INFORMED CONSENT;
MALE;
NEUROPATHIC PAIN;
POINT MUTATION;
PRIORITY JOURNAL;
SYSTOLE;
ADULT;
ALPHA-GALACTOSIDASE;
CARDIOMEGALY;
FABRY DISEASE;
HUMANS;
MALE;
POINT MUTATION;
RECOMBINANT PROTEINS;
VENTRICULAR DYSFUNCTION, LEFT;
|
EID: 2442648874
PISSN: 13556037
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|